Cargando…
Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic‐refractory congestive heart failure: the SEMI‐SEC project
AIMS: Hyponatraemia is an electrolyte disorder that occurs in advanced congestive heart failure (HF) and worsens prognosis. We explored the usefulness of tolvaptan, which has shown promising results in the treatment of this condition. METHODS AND RESULTS: This study is based on a retrospective natio...
Autores principales: | Pose, Antonio, Almenar, Luis, Gavira, Juan José, López‐Granados, Amador, Blasco, Teresa, Delgado, Juan, Aramburu, Oscar, Rodríguez, Avelino, Manzano, Luis, Manito, Nicolás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396041/ https://www.ncbi.nlm.nih.gov/pubmed/28451449 http://dx.doi.org/10.1002/ehf2.12124 |
Ejemplares similares
-
Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016) -
Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden
por: Jamookeeah, Clare, et al.
Publicado: (2016) -
Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients
por: Tosh, Pulak, et al.
Publicado: (2017) -
Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
por: Kramers, Bart J., et al.
Publicado: (2018) -
The Role of Fractional Excretion of Uric Acid in the Differential Diagnosis of Hypotonic Hyponatraemia in Patients with Diuretic Therapy
por: Bassi, Vincenzo, et al.
Publicado: (2020)